Publications by authors named "Craig M Bula"

Claim this Profile
O
On the mechanism underlying (23S)-25-dehydro-1alpha(OH)-vitamin D3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonist.
Mathew T Mizwicki, Craig M Bula, Paween Mahinthichaichan, Helen L Henry, Seiichi Ishizuka

J Biol Chem· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model.
Mathew T Mizwicki, Craig M Bula, June E Bishop, Anthony W Norman

J Steroid Biochem Mol Biol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conservative mutageneic perturbations of amino acids connecting helix 12 in the 1alpha,25(OH)2-D3 receptor (VDR) to the ligand cause significant transactivational effects.
Craig M Bula, June E Bishop, Anthony W Norman

J Steroid Biochem Mol Biol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice.
Craig M Bula, Johanna Huhtakangas, Christopher Olivera, June E Bishop, Anthony W Norman

Endocrinology· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols.
Mathew T Mizwicki, Craig M Bula, June E Bishop, Anthony W Norman

J Steroid Biochem Mol Biol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
Anthony M Vertino, Craig M Bula, Jin-Ran Chen, Maria Almeida, Li Han

J Biol Chem· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of 25-hydroxyl group orientation on biological activity and binding to the 1alpha,25-dihydroxy vitamin D3 receptor.
Elaine D Collins, June E Bishop, Craig M Bula, Alejandra Acevedo, William H Okamura

J Steroid Biochem Mol Biol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.
Mathew T Mizwicki, Don Keidel, Craig M Bula, June E Bishop, Laura P Zanello

Proc Natl Acad Sci U S A· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties.
Christopher J Olivera, Craig M Bula, June E Bishop, Luciano Adorini, Percy Manchand

J Steroid Biochem Mol Biol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3).
Anthony W Norman, June E Bishop, Craig M Bula, Christopher J Olivera, Mathew T Mizwicki

Steroids· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis